Works matching IS 01495992 AND DT 2023 AND VI 46 AND IP 9

Results: 27
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Issues and Events.

    Published in:
    Diabetes Care, 2023, v. 46, n. 9, p. 1723, doi. 10.2337/dc23-ie09
    Publication type:
    Article
    10

    Erratum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S49–S67.

    Published in:
    2023
    By:
    • ElSayed, Nuha A.;
    • Aleppo, Grazia;
    • Aroda, Vanita R.;
    • Bannuru, Raveendhara R.;
    • Brown, Florence M.;
    • Bruemmer, Dennis;
    • Collins, Billy S.;
    • Cusi, Kenneth;
    • Hilliard, Marisa E.;
    • Isaacs, Diana;
    • Johnson, Eric L.;
    • Kahan, Scott;
    • Khunti, Kamlesh;
    • Leon, Jose;
    • Lyons, Sarah K.;
    • Perry, Mary Lou;
    • Prahalad, Priya;
    • Pratley, Richard E.;
    • Seley, Jane Jeffrie;
    • Stanton, Robert C.
    Publication type:
    Correction Notice
    11

    Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA<sub>1c</sub> and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897.

    Published in:
    2023
    By:
    • Rossing, Peter;
    • Burgess, Ellen;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Gillard, Pieter;
    • MacIsaac, Richard J.;
    • Wainstein, Julio;
    • Joseph, Amer;
    • Brinker, Meike;
    • Roessig, Lothar;
    • Scott, Charlie;
    • Bakris, George L.;
    • FIDELIO-DKD Investigators;
    • Vallejos, Augusto;
    • MacIsaac, Richard;
    • Schernthaner, Guntram;
    • Canziani, Maria Eugenia F.
    Publication type:
    Correction Notice
    12

    Addendum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S49–S67.

    Published in:
    2023
    By:
    • ElSayed, Nuha A.;
    • Aleppo, Grazia;
    • Aroda, Vanita R.;
    • Bannuru, Raveendhara R.;
    • Brown, Florence M.;
    • Bruemmer, Dennis;
    • Collins, Billy S.;
    • Cusi, Kenneth;
    • Hilliard, Marisa E.;
    • Isaacs, Diana;
    • Johnson, Eric L.;
    • Kahan, Scott;
    • Khunti, Kamlesh;
    • Leon, Jose;
    • Lyons, Sarah K.;
    • Perry, Mary Lou;
    • Prahalad, Priya;
    • Pratley, Richard E.;
    • Seley, Jane Jeffrie;
    • Stanton, Robert C.
    Publication type:
    Correction Notice
    13

    Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S41–S48.

    Published in:
    2023
    By:
    • ElSayed, Nuha A.;
    • Aleppo, Grazia;
    • Aroda, Vanita R.;
    • Bannuru, Raveendhara R.;
    • Brown, Florence M.;
    • Bruemmer, Dennis;
    • Collins, Billy S.;
    • Hilliard, Marisa E.;
    • Isaacs, Diana;
    • Johnson, Eric L.;
    • Kahan, Scott;
    • Khunti, Kamlesh;
    • Leon, Jose;
    • Lyons, Sarah K.;
    • Perry, Mary Lou;
    • Prahalad, Priya;
    • Pratley, Richard E.;
    • Seley, Jane Jeffrie;
    • Stanton, Robert C.;
    • Gabbay, Robert A.
    Publication type:
    Correction Notice
    14

    Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S19–S40.

    Published in:
    2023
    By:
    • ElSayed, Nuha A.;
    • Aleppo, Grazia;
    • Aroda, Vanita R.;
    • Bannuru, Raveendhara R.;
    • Brown, Florence M.;
    • Bruemmer, Dennis;
    • Collins, Billy S.;
    • Hilliard, Marisa E.;
    • Isaacs, Diana;
    • Johnson, Eric L.;
    • Kahan, Scott;
    • Khunti, Kamlesh;
    • Leon, Jose;
    • Lyons, Sarah K.;
    • Perry, Mary Lou;
    • Prahalad, Priya;
    • Pratley, Richard E.;
    • Seley, Jane Jeffrie;
    • Stanton, Robert C.;
    • Gabbay, Robert A.
    Publication type:
    Correction Notice
    15
    16
    17
    18
    19
    20
    21

    A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA<sub>1c</sub> ≥9–15%: DUAL HIGH Trial.

    Published in:
    Diabetes Care, 2023, v. 46, n. 9, p. 1640, doi. 10.2337/dc22-2426
    By:
    • Galindo, Rodolfo J.;
    • Moazzami, Bobak;
    • Scioscia, Maria F.;
    • Zambrano, Cesar;
    • Albury, Bonnie S.;
    • Saling, Jarrod;
    • Vellanki, Priyathama;
    • Pasquel, Francisco J.;
    • Davis, Georgia M.;
    • Fayfman, Maya;
    • Peng, Limin;
    • Umpierrez, Guillermo E.
    Publication type:
    Article
    22
    23

    Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort.

    Published in:
    Diabetes Care, 2023, v. 46, n. 9, p. 1681, doi. 10.2337/dc23-0206
    By:
    • Debras, Charlotte;
    • Deschasaux-Tanguy, Mélanie;
    • Chazelas, Eloi;
    • Sellem, Laury;
    • Druesne-Pecollo, Nathalie;
    • Esseddik, Younes;
    • Szabo de Edelenyi, Fabien;
    • Agaësse, Cédric;
    • De Sa, Alexandre;
    • Lutchia, Rebecca;
    • Julia, Chantal;
    • Kesse-Guyot, Emmanuelle;
    • Allès, Benjamin;
    • Galan, Pilar;
    • Hercberg, Serge;
    • Huybrechts, Inge;
    • Cosson, Emmanuel;
    • Tatulashvili, Sopio;
    • Srour, Bernard;
    • Touvier, Mathilde
    Publication type:
    Article
    24
    25
    26
    27